A detailed history of New Edge Advisors, LLC transactions in Cybin Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 4,771 shares of CYBN stock, worth $1,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,771
Previous 4,771 -0.0%
Holding current value
$1,240
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.38 - $0.65 $1,381 - $2,363
3,636 Added 320.35%
4,771 $1,000
Q1 2023

May 12, 2023

SELL
$0.3 - $0.56 $725 - $1,354
-2,418 Reduced 68.06%
1,135 $0
Q4 2022

Feb 14, 2023

BUY
$0.26 - $0.47 $923 - $1,669
3,553 New
3,553 $1,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.